Endocrine Pharmaceuticals Limited

Active03005721 Private limited company
Incorporated
4 January 1995 (31 years)
Industry
Other research and experimental development on natural sciences and engineering (72190)
Directors
Gavin Fairlie Douglas
Owned by
John Ernest Hart
Accounts type
Total exemption full
Region
South East
Address
Wilderness End
Tadley Common Road
Tadley
RG26 3TA

Filing status

Accounts due
31 March 2028
Last accounts
30 June 2026
Conf. stmt due
29 March 2027
Last conf. stmt
15 March 2026

Officers 4 active

Officer details are public data from the Companies House register.

Douglas, Gavin Fairlie
Director · Appointed 30 June 2020
British
Born April 1972 (54)
Director · Appointed 13 January 2014
British
Born August 1945 (81)
Hart, Juliet Fay
Secretary · Appointed 9 September 2005
British
Director · Appointed 22 May 1995
British
Born December 1953 (72)
Officer history (19 former)
30 June 2020
Appointed Douglas, Gavin Fairlie as Director
30 June 2020
Resigned Walker, Timothy Graham as Director
13 January 2014
Appointed Fairlie, Lyell William as Director
8 January 2013
Resigned Fox, John Stephen, Dr as Director
29 November 2006
Resigned Agg, Philip James as Director
10 March 2006
Appointed Agg, Philip James as Director
10 March 2006
Resigned Asher, James as Director
9 September 2005
Appointed Hart, Juliet Fay as Secretary
8 July 2005
Resigned Thornton, Andrew Robert as Secretary
28 June 2004
Appointed Walker, Timothy Graham as Director
15 March 2004
Resigned Bonner, Frank William as Director
12 February 2004
Resigned Copsey, David Bernard, Dr as Director
22 January 2004
Resigned Buckley Golder, Ian Mark, Dr as Director
11 September 2003
Appointed Fox, John Stephen, Dr as Director
27 March 2003
Appointed Asher, James as Director
27 March 2003
Resigned Raybone, David as Director
11 May 2001
Resigned Wren, Graham, Eur Ing as Director
3 May 2001
Appointed Raybone, David as Director
11 May 2000
Appointed Wren, Graham, Eur Ing as Director
9 February 2000
Resigned Pope, Nicholas Robert, Dr as Director
9 December 1999
Resigned Coombes, James David as Director
8 October 1999
Appointed Thornton, Andrew Robert as Secretary
8 October 1999
Resigned Hart, Juliet Fay as Secretary
8 October 1999
Resigned Roe, Simon Dennis as Director
8 October 1999
Appointed Buckley Golder, Ian Mark, Dr as Director
8 October 1999
Appointed Pope, Nicholas Robert, Dr as Director
17 July 1998
Appointed Coombes, James David as Director
17 July 1998
Appointed Roe, Simon Dennis as Director
3 June 1998
Appointed Bonner, Frank William as Director
22 November 1996
Appointed Copsey, David Bernard, Dr as Director
25 October 1996
Resigned Templeton, Robert Ian as Director
25 October 1996
Appointed Hart, Juliet Fay as Secretary
25 October 1996
Resigned Templton, Ian as Secretary
25 October 1996
Resigned Morley, Harold as Director
22 May 1995
Appointed Hart, John Ernest, Dr as Director
7 April 1995
Appointed Templton, Ian as Secretary
7 April 1995
Appointed Morley, Harold as Director
7 April 1995
Resigned Jones, Kathryn Louise as Nominee Secretary
7 April 1995
Resigned Stephens, Graham Robertson as Nominee Director
7 January 1995
Appointed Templeton, Robert Ian as Director
4 January 1995
Appointed Jones, Kathryn Louise as Nominee Secretary
4 January 1995
Appointed Stephens, Graham Robertson as Nominee Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Individual · Notified 5 January 2017
Owns 25–50% of shares
Holds 25–50% of voting rights
British
Born December 1953 (72)

Financials

Cash
£1,521
Profit
(£11,276)
Employees
3

Trend

Shareholder Funds
(£100k) (£50k) £0 2020 2021 2022 2023 2024 2025 (£67,555) (£69,532) (£76,998) (£87,509) (£90,035) (£99,311)
Balance sheet detail
202520242023202220212020
Cash£1,521£5,187£2,160£6,596£8,878£4,811
Creditors (< 1 year)£100,832£95,222£89,669£83,594£78,410£72,366
Net Current Assets(£99,311)(£90,035)(£87,509)(£76,998)(£69,532)(£67,555)
Shareholder Funds(£99,311)(£90,035)(£87,509)(£76,998)(£69,532)(£67,555)

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
16 March 2026Confirmation statement with no updates15 March 2026
12 September 2025Total exemption full accounts30 June 2025
17 March 2025Confirmation statement with updates15 March 2025
6 March 2025Statement of capital following an allotment of shares
29 August 2024Total exemption full accounts30 June 2024
Show all recent filings

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?